Safety and Effectiveness of Adalimumab for the Treatment of Pyoderma Gangrenosum: A 52-Week Real-World Prospective Observational Study
-
By
-
Toshiyuki Yamamoto
-
Hideaki Tanizaki
-
Kenshi Yamasaki
-
Naoko Matsubara
-
Masahiko Nakayama
-
Eri Iwashita
-
Keiichi Yamanaka
-
May 10, 2026